Back
Akero Therapeutics Vs. Surmodics Industry Stock Comparison
Sell
42
AKRO
Akero Therapeutics
Last Price:
20.71
Seasonality Move:
17.5%
Sell
42
SRDX
Surmodics
Last Price:
34.08
Seasonality Move:
10.22%
Sell
42
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $21.07. The Score for AKRO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Surmodics (SRDX)
is a Sell
Is Surmodics a Buy, Sell or Hold?
- The current Surmodics [SRDX] share price is $33.56. The Score for SRDX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- SRDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $21.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight selling pressure.
SRDX Stock Price Chart
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.53 | Sell |
| Relative Strength Index (14 RSI): | 49 | Sell |
| Chaikin Money Flow: | -37322 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.8 - 21.62) | Buy |
| Bollinger Bands (100): | (20.16 - 26.02) | Sell |
SRDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.41 | Buy |
| Relative Strength Index (14 RSI): | 66.75 | Buy |
| Chaikin Money Flow: | -3104 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.94 - 32.36) | Buy |
| Bollinger Bands (100): | (27.93 - 34.35) | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.95 | Buy |
| 20-day SMA: | 20.43 | Buy |
| 50-day SMA: | 23.26 | Sell |
| 200-day SMA: | 27.32 | Sell |
| 8-day EMA: | 20.64 | Buy |
| 20-day EMA: | 20.91 | Buy |
| 50-day EMA: | 22.05 | Sell |
| 200-day EMA: | 26.6 | Sell |
SRDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.42 | Buy |
| 20-day SMA: | 29.74 | Buy |
| 50-day SMA: | 28.73 | Buy |
| 200-day SMA: | 32.42 | Buy |
| 8-day EMA: | 32.33 | Buy |
| 20-day EMA: | 30.69 | Buy |
| 50-day EMA: | 29.89 | Buy |
| 200-day EMA: | 30.9 | Buy |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.06 per share, a decrease this year of $1.16 per share, and a decrease next year of $0.35 per share.
Surmodics Earnings Growth & SRDX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.37 per share, and an increase next year of $0.30 per share.
Akero Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Surmodics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||